PENUMBRA INC (PEN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:PEN • US70975L1070

339.92 USD
-16.08 (-4.52%)
At close: Feb 4, 2026
341 USD
+1.08 (+0.32%)
After Hours: 2/4/2026, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, PEN scores 6 out of 10 in our fundamental rating. PEN was compared to 186 industry peers in the Health Care Equipment & Supplies industry. PEN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PEN is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PEN suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year PEN was profitable.
  • In the past year PEN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: PEN reported negative operating cash flow in multiple years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • With an excellent Return On Assets value of 9.40%, PEN belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
  • PEN's Return On Equity of 12.07% is amongst the best of the industry. PEN outperforms 88.71% of its industry peers.
  • The Return On Invested Capital of PEN (7.37%) is better than 82.26% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for PEN is significantly below the industry average of 8.80%.
  • The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROIC 7.37%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

  • The Profit Margin of PEN (12.30%) is better than 88.17% of its industry peers.
  • PEN's Profit Margin has declined in the last couple of years.
  • PEN's Operating Margin of 12.95% is amongst the best of the industry. PEN outperforms 80.65% of its industry peers.
  • In the last couple of years the Operating Margin of PEN has declined.
  • The Gross Margin of PEN (66.80%) is better than 71.51% of its industry peers.
  • PEN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

  • PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PEN has been reduced compared to 1 year ago.
  • PEN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PEN has an improved debt to assets ratio.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 23.60 indicates that PEN is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of PEN (23.60) is better than 96.77% of its industry peers.
  • The Debt to FCF ratio of PEN is 0.15, which is an excellent value as it means it would take PEN, only 0.15 years of fcf income to pay off all of its debts.
  • PEN has a Debt to FCF ratio of 0.15. This is amongst the best in the industry. PEN outperforms 93.01% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that PEN is not too dependend on debt financing.
  • PEN has a Debt to Equity ratio of 0.02. This is in the better half of the industry: PEN outperforms 72.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 23.6
ROIC/WACC0.73
WACC10.16%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 6.73 indicates that PEN has no problem at all paying its short term obligations.
  • The Current ratio of PEN (6.73) is better than 85.48% of its industry peers.
  • A Quick Ratio of 4.18 indicates that PEN has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 4.18, PEN is in the better half of the industry, outperforming 76.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.73
Quick Ratio 4.18
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 36.47% over the past year.
  • Measured over the past years, PEN shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.23% on average per year.
  • Looking at the last year, PEN shows a quite strong growth in Revenue. The Revenue has grown by 14.61% in the last year.
  • Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 16.89% on average per year.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.42% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.24% on average over the next years. This is quite good.
EPS Next Y32.98%
EPS Next 2Y33.42%
EPS Next 3Y31.48%
EPS Next 5Y24.42%
Revenue Next Year16.21%
Revenue Next 2Y15.29%
Revenue Next 3Y14.8%
Revenue Next 5Y13.24%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

4

4. Valuation

4.1 Price/Earnings Ratio

  • PEN is valuated quite expensively with a Price/Earnings ratio of 93.64.
  • Compared to the rest of the industry, the Price/Earnings ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 66.67% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, PEN is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 66.54, the valuation of PEN can be described as expensive.
  • PEN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 67.20% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.50. PEN is valued rather expensively when compared to this.
Industry RankSector Rank
PE 93.64
Fwd PE 66.54
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PEN is valued a bit cheaper than the industry average as 65.05% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, PEN is valued a bit cheaper than 69.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 87.22
EV/EBITDA 70.17
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • PEN has a very decent profitability rating, which may justify a higher PE ratio.
  • PEN's earnings are expected to grow with 31.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.84
PEG (5Y)3.86
EPS Next 2Y33.42%
EPS Next 3Y31.48%

0

5. Dividend

5.1 Amount

  • No dividends for PEN!.
Industry RankSector Rank
Dividend Yield 0%

PENUMBRA INC

NYSE:PEN (2/4/2026, 8:04:00 PM)

After market: 341 +1.08 (+0.32%)

339.92

-16.08 (-4.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-24
Inst Owners97.98%
Inst Owner Change-0.16%
Ins Owners3.7%
Ins Owner Change2.01%
Market Cap13.31B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts85.83
Price Target342.61 (0.79%)
Short Float %4.59%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)1.25%
PT rev (3m)6.92%
EPS NQ rev (1m)1.57%
EPS NQ rev (3m)-0.34%
EPS NY rev (1m)0.28%
EPS NY rev (3m)1.09%
Revenue NQ rev (1m)1.32%
Revenue NQ rev (3m)1.39%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 93.64
Fwd PE 66.54
P/S 9.98
P/FCF 87.22
P/OCF 65.48
P/B 9.8
P/tB 11.23
EV/EBITDA 70.17
EPS(TTM)3.63
EY1.07%
EPS(NY)5.11
Fwd EY1.5%
FCF(TTM)3.9
FCFY1.15%
OCF(TTM)5.19
OCFY1.53%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.84
PEG (5Y)3.86
Graham Number53.23
Profitability
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROCE 10.97%
ROIC 7.37%
ROICexc 10.5%
ROICexgc 12.46%
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
FCFM 11.44%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA 0.11
Cap/Depr 291.22%
Cap/Sales 3.8%
Interest Coverage 250
Cash Conversion 106.89%
Profit Quality 93.05%
Current Ratio 6.73
Quick Ratio 4.18
Altman-Z 23.6
F-Score7
WACC10.16%
ROIC/WACC0.73
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y32.98%
EPS Next 2Y33.42%
EPS Next 3Y31.48%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year16.21%
Revenue Next 2Y15.29%
Revenue Next 3Y14.8%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year80.23%
EBIT Next 3Y41.84%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PEN.


What is the valuation status of PENUMBRA INC (PEN) stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


Can you provide the profitability details for PENUMBRA INC?

PENUMBRA INC (PEN) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for PEN stock?

The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 32.98% in the next year.